JNPMEDI attended the "KIMES 2022" (37th International Medical Device and Hospital Equipment Exhibition), the largest international medical device and hospital facility exhibition in Korea.

JNPMEDI
05 Apr 2022 · 4 minutes read

JNPMEDI attended the "KIMES 2022" (37th International Medical Device and Hospital Equipment Exhibition), the largest international medical device and hospital facility exhibition in Korea.

KIMES 2022

JNPMEDI attended the "KIMES 2022" (37th International Medical Device and Hospital Equipment Exhibition), the largest international medical device and hospital facility exhibition in Korea. Based on the recent COVID-19 pandemic and rapid social changes, the spread of industries such as digital therapy devices, medical artificial intelligence (AI), and software has been noticeable this year. A total of 1,258 companies from 38 countries participated, and JNPMEDI also participated to add strength to the changing industrial atmosphere.

JNPMEDI had an introduction to Maven Docs, a clinical trial document management solution, as well as a Maven Clinical Data Management System (CDMS) solution. Interest was high in "Maven DCT Suite," a family of decentralized clinical trials (DCTs) and "Maven DTx Suite," a clinical trial support service for digital therapeutics, which has recently become a hot topic.

As clinical trials on medical devices are becoming increasingly important through combination with the latest digital technologies, this KIMES exhibition has gained a lot of interest and interest from various medical companies and hospital officials. In addition, we were able to provide valuable opportunities to feel the high interest of the market by leading several consultations, demonstrations, and follow-up meetings.

In the future, JNPMEDI will continue to participate in various domestic and international exhibitions to promote the excellence of our clinical trial data management solutions.

Tags:
Maven Clinical Cloud
Event

Your Partner for a Successful Journey

JNPMEDI has been putting effort on bringing disruption on healthcare industry via integrating digital technologies to clinical research & trial operations.